Described is a fuser member including a substrate and a release layer disposed on the substrate. The release layer includes a fluoropolymer having a plurality of metal fibers having a diameter of from about 5 nanometers to about 20 microns dispersed throughout the fluoropolymer. A method of manufacturing the fuser member is also provided.

The disclosure is directed to a chemically strengthened glass having antimicrobial properties and to a method of making such glass. In particular, the disclosure is directed to a chemically strengthened glass with antimicrobial properties and with a low surface energy coating on the glass that does not interfere with the antimicrobial properties of the glass. The antimicrobial has an Ag ion concentration on the surface in the range of greater than zero to 0.047 g/cm.sup.2. The glass has particular applications as antimicrobial shelving, table tops and other applications in hospitals, laboratories and other institutions handling biological substances, where color in the glass is not a consideration.

Glass pharmaceutical packages with coatings are disclosed herein. According to one embodiment, the glass pharmaceutical package includes a glass body enclosing an inner volume and having an exterior surface. A coating may be positioned on at least a portion of the exterior surface of the glass body. The coating may include a coupling agent layer having a first thickness of greater than or equal to 25 nm and less than or equal to 100 nm. A polymer layer having a second thickness of less than 50 nm may be positioned over the coupling agent layer.

In the case of a structural glass element with a plastic-coated glass panel and at least one assembly element attached hereon, the glass panel is coated in particular with a silicone-based elastomer across its entire surface, and the coating at the same time creates an adhesive joint with one section of the assembly element supported on the glass panel.

An object having a coating produced using an adhesion promoter, wherein the adhesion promoter comprises at least one, optionally oligomeric, addition product having no terminal CC double bonds and having hydrolyzable silane groups.

Paint formulations having a high absorptivity with respect to solar radiation are disclosed herein. The disclosed paint formulations are also thermally and mechanically durable, thereby enabling the paint formulations to be used on components in solar thermal applications where exposure to high temperatures and environmental conditions may be an issue. The paint formulation can include an oxide-based pigment, an organic binder, one or more additives, an inorganic filler, and/or an organic solvent. The pigment can have a relatively high absorptivity with respect to light having a wavelength in the range from 250 nm to 3000 nm. Curing of the paint formulation can irreversibly convert the organic binder into an inorganic binder.

A coated glass pharmaceutical package may include a body formed from a Type 1 Class glass according to ASTM Standard E438-92. The body may have an interior surface and an exterior surface. The body may also have at least a class A2 base resistance or better according to ISO 695, at least a type HGB2 hydrolytic resistance or better according to ISO 719 and a Type 1 chemical durability according to USP <660>. A coating having a thickness of 100 microns may be positioned on at least a portion of the exterior surface. The portion of the exterior surface with the coating may have a coefficient of friction that is at least 20% less than an uncoated glass pharmaceutical package and the coefficient of friction does not increase by more than 30% after undergoing a depyrogenation.

A curable composition including: (a) 100 parts by mass of a siloxane oligomer containing at least one radically polymerizable double bond, (b) 0.001 to 1 part by mass of a fluorine-containing highly branched polymer, (c) 0.01 to 40 parts by mass of a surface modifier containing a perfluoropolyether compound, and (d) 0.1 to 25 parts by mass of a polymerization initiator generating a radical upon active energy ray irradiation, wherein the fluorine-containing highly branched polymer (b) is a fluorine-containing highly branched polymer obtained by polymerization of a monomer A containing two or more radically polymerizable double bonds per molecule and a monomer B containing a fluoroalkyl group and at least one radically polymerizable double bond per molecule in the presence of a polymerization initiator C in an amount of 5 to 200 mol % with respect to the number of moles of the monomer A.

Novel, lubricious coatings for medical devices are disclosed. The coatings provide improved lubricity and durability, and are readily applied in coating processes. The present invention is also directed to a novel platinum catalyst for use in such coatings. The catalyst provides for rapid curing, while inhibiting cross-linking at ambient temperatures, thereby improving the production pot life of the coatings.

The invention relates to the use of polyolefins modified with one or more silanes as adhesion promoters for the production of flat glass/glass, glass/plastic, or plastic/plastic laminates, to corresponding laminates, and to displays containing the laminates according to the invention.